Expressive Writing for Individuals With Parkinson's Disease and Their Caregivers
NCT ID: NCT02217735
Last Updated: 2023-10-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2011-08-31
2013-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Results from this study will determine whether brief writing exercises are easily used by and beneficial for individuals with Parkinson's Disease and their support persons. If positive benefit is observed, information from this study will be used to further optimize these therapies for larger trials designed to evaluate the value of the therapies for individuals with Parkinson's Disease and their support persons.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Consolidation of Motor Learning of Writing Skills and Its Related Brain Activity Changes in Parkinson's Disease
NCT02288052
Handwriting Rehabilitation in Parkinson Disease
NCT02718560
A Trial of Neurocognitive and Supportive Therapy Interventions for Individuals With Parkinson's Disease
NCT01646333
Self-controlled Practice on Motor Learning and Motivation in Parkinson's Disease
NCT07028515
Effects of Transcranial Direct Current Stimulation on Fine Motor Skills in Parkinson's Disease: a Pilot Study
NCT02287207
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Writing Intervention - Expressive Arm
Participants are asked to write about the most traumatic or stressful experience of their entire lives in three, 20 minute writing sessions.
Writing Intervention
Participants wrote for 20 minutes on three occasions about an emotional or traumatic topic (expressive writing intervention condition) or what they did the day before, while refraining from including emotional details.
Writing Intervention - Neutral Arm
Participants are asked to write about what they did the day before, refraining from including emotional details.
Writing Intervention
Participants wrote for 20 minutes on three occasions about an emotional or traumatic topic (expressive writing intervention condition) or what they did the day before, while refraining from including emotional details.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Writing Intervention
Participants wrote for 20 minutes on three occasions about an emotional or traumatic topic (expressive writing intervention condition) or what they did the day before, while refraining from including emotional details.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Virginia Commonwealth University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sarah K. Lageman, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Virginia Commonwealth University
James P. Bennett, M.D., Ph.D.
Role: STUDY_CHAIR
Virginia Commonwealth University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VCU Parkinson's and Movement Disorders Center
Richmond, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Cash TV, Lageman SK. Randomized controlled expressive writing pilot in individuals with Parkinson's disease and their caregivers. BMC Psychol. 2015 Nov 30;3:44. doi: 10.1186/s40359-015-0101-4.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HM#13659
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.